Table S12 from Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Table S12 shows the summary of glecirasib's genotoxicity and phototoxicity studies.
Fields of Study & Subjects
Protein Kinase Regulation and GTPase Signaling
Melanoma and MAPK Pathways
Lung Cancer Treatments and Mutations
Publication details
- Publication date
- 16 March 2026
- Language
- EN